| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-15 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-13 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-12 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-10 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-10 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-10 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-09 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-08 |